X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1454) 1454
Publication (149) 149
Book Review (27) 27
Book Chapter (22) 22
Book / eBook (12) 12
Conference Proceeding (2) 2
Dissertation (2) 2
Magazine Article (2) 2
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1103) 1103
percutaneous coronary intervention (941) 941
index medicus (830) 830
male (598) 598
female (588) 588
cardiac & cardiovascular systems (577) 577
middle aged (502) 502
aged (480) 480
treatment outcome (384) 384
mortality (328) 328
angioplasty (293) 293
risk factors (267) 267
cost-benefit analysis (249) 249
stents (212) 212
time factors (195) 195
heart attacks (187) 187
acute myocardial-infarction (185) 185
retrospective studies (182) 182
care and treatment (177) 177
cardiovascular disease (175) 175
outcomes (175) 175
cardiology (172) 172
percutaneous coronary intervention - economics (172) 172
adult (167) 167
myocardial infarction (167) 167
coronary artery disease (161) 161
medicine, general & internal (161) 161
abridged index medicus (160) 160
myocardial infarction - therapy (156) 156
aged, 80 and over (154) 154
patients (154) 154
transluminal angioplasty (153) 153
cardiovascular diseases (150) 150
intervention (150) 150
analysis (144) 144
coronary heart disease (143) 143
research (141) 141
drug-eluting stents (136) 136
surgery (129) 129
cardiac patients (124) 124
medicine (123) 123
studies (123) 123
percutaneous coronary intervention - methods (122) 122
revascularization (122) 122
percutaneous coronary intervention - adverse effects (118) 118
usage (117) 117
cost-effectiveness (116) 116
platelet aggregation inhibitors - therapeutic use (115) 115
angiography (113) 113
hospitals (112) 112
united states (111) 111
disease (109) 109
myocardial-infarction (109) 109
artery-disease (108) 108
cardiovascular (108) 108
follow-up studies (106) 106
health aspects (106) 106
management (105) 105
prospective studies (103) 103
coronary artery disease - therapy (102) 102
heart attack (102) 102
coronary vessels (101) 101
coronary artery bypass (100) 100
clopidogrel (99) 99
health care sciences & services (99) 99
acute coronary syndromes (98) 98
myocardial infarction - mortality (95) 95
trial (94) 94
risk assessment (93) 93
registries (89) 89
angioplasty, balloon, coronary - economics (86) 86
health care costs (86) 86
therapy (85) 85
acute coronary syndrome (83) 83
research article (83) 83
ticlopidine - analogs & derivatives (83) 83
coronary artery disease - surgery (82) 82
peripheral vascular disease (80) 80
hospital costs (78) 78
metaanalysis (78) 78
myocardial infarction - economics (77) 77
risk (77) 77
coronary angiography (76) 76
percutaneous transluminal coronary angioplasty (76) 76
pharmacology & pharmacy (75) 75
socioeconomic factors (73) 73
coronary artery disease - economics (72) 72
impact (72) 72
patient outcomes (72) 72
randomized controlled trials as topic (72) 72
elevation myocardial-infarction (71) 71
stent (70) 70
follow-up (68) 68
percutaneous coronary intervention - mortality (68) 68
prognosis (68) 68
quality of life (68) 68
association (67) 67
drug therapy (67) 67
electrocardiography (67) 67
heart (67) 67
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1461) 1461
Italian (8) 8
German (6) 6
Polish (5) 5
Spanish (5) 5
Portuguese (4) 4
Chinese (2) 2
Russian (2) 2
Croatian (1) 1
French (1) 1
Japanese (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 2014, Volume 130, Issue 14, pp. 1146 - 1157
Background-The Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial demonstrated that in patients with 3-vessel or... 
Cost-benefit analysis | Percutaneous coronary intervention | Randomized, controlled trials as topic | Coronary artery bypass | Drug-eluting stents | FRACTIONAL FLOW RESERVE | MULTIVESSEL DISEASE | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | drug-eluting stents | ARGENTINE RANDOMIZED-TRIAL | coronary artery bypass | MEDICAL COSTS | randomized, controlled trials as topic | percutaneous coronary intervention | ECONOMIC-EVALUATION | ANGIOPLASTY | 5-YEAR FOLLOW-UP | cost-benefit analysis | CLINICAL-TRIALS | PERIPHERAL VASCULAR DISEASE | QUALITY-OF-LIFE | Hospital Costs | Quality-Adjusted Life Years | Coronary Artery Disease - surgery | Coronary Artery Bypass - methods | Coronary Artery Disease - economics | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Drug-Eluting Stents - economics | Male | Treatment Outcome | Coronary Artery Disease - mortality | Physicians - economics | Coronary Artery Bypass - economics | Coronary Artery Bypass - mortality | Percutaneous Coronary Intervention - methods | Cost-Benefit Analysis | Quality of Life | Coronary Vessels - surgery | Drug-Eluting Stents - statistics & numerical data | Female | Aged | Ambulatory Care - economics | Percutaneous Coronary Intervention - economics | Heart | Care and treatment | Usage | Coronary heart disease | Surgery | Risk factors
Journal Article
Journal Article
PharmacoEconomics, ISSN 1170-7690, 11/2013, Volume 31, Issue 11, pp. 959 - 970
Journal Article
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2013, Volume 6, Issue 8, pp. 827 - 834
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 01/2013, Volume 11, Issue 1, pp. 81 - 91
Background:  The CYP2C19 genotype is a predictor of adverse cardiovascular events in acute coronary syndrome (ACS) patients undergoing percutaneous coronary... 
clopidogrel | cost‐effectiveness | prasugrel | antiplatelet therapy | genetic testing | acute coronary syndromes | Antiplatelet therapy | Prasugrel | Clopidogrel | Genetic testing | Acute coronary syndromes | Cost-effectiveness | cost-effectiveness | LAST YEAR | CYP2C19 GENOTYPE | TREATED PATIENTS | BYPASS GRAFT-SURGERY | ATRIAL-FIBRILLATION | ACUTE MYOCARDIAL-INFARCTION | PERIPHERAL VASCULAR DISEASE | ST-SEGMENT ELEVATION | HEMATOLOGY | OF-CARE | CLINICAL-OUTCOMES | Prasugrel Hydrochloride | Predictive Value of Tests | Thiophenes - therapeutic use | Percutaneous Coronary Intervention - mortality | Acute Coronary Syndrome - economics | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Thiophenes - metabolism | Medicare - economics | Models, Economic | Pharmacogenetics - economics | Time Factors | Ticlopidine - economics | Myocardial Infarction - etiology | Insurance, Health, Reimbursement - economics | Quality-Adjusted Life Years | Genetic Predisposition to Disease | Risk Assessment | Gene Frequency | Risk Factors | Piperazines - therapeutic use | Ticlopidine - analogs & derivatives | Phenotype | Acute Coronary Syndrome - therapy | Thrombosis - genetics | Percutaneous Coronary Intervention - economics | Percutaneous Coronary Intervention - adverse effects | Thrombosis - economics | Drug Costs | Platelet Aggregation Inhibitors - economics | Markov Chains | Ticlopidine - therapeutic use | United States | Acute Coronary Syndrome - mortality | Piperazines - economics | Piperazines - metabolism | Computer Simulation | Hemorrhage - etiology | Ticlopidine - metabolism | Thiophenes - economics | Platelet Aggregation Inhibitors - metabolism | Thrombosis - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Decision Support Techniques | Kaplan-Meier Estimate | Treatment Outcome | Cerebrovascular Disorders - etiology | Aryl Hydrocarbon Hydroxylases - metabolism | Disease-Free Survival | Health Care Costs | Cytochrome P-450 CYP2C19 | Cost-Benefit Analysis | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - genetics | Genetic Testing - economics | Transluminal angioplasty | Care and treatment | Medicare | Analysis | Cardiac patients | Cytochrome P-450 | Markov processes | Cost benefit analysis | Coronary heart disease | Genetic screening | Angina pectoris | Genotype & phenotype
Journal Article
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 12/2017, Volume 10, Issue 12
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 02/2018, Volume 11, Issue 3, pp. 225 - 233
Journal Article
Heart, ISSN 1355-6037, 12/2015, Volume 101, Issue 24, pp. 1980 - 1988
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 12/2016, Volume 88, Issue 7, pp. 1017 - 1024
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 12/2014, Volume 84, Issue 7, pp. 1029 - 1039
Journal Article
Circulation: Cardiovascular Quality and Outcomes, ISSN 1941-7713, 06/2018, Volume 11, Issue 6, p. e004328
Journal Article